Table 3.
Correlations between serum lipid levels and cancerous tissue of patients with colorectal cancer with the tumor node metastasis stages
| Groups | Case (n) | TCH | FCH | TG | HDL-C | LDL-C |
| Tissue (μmol/g) | ||||||
| I | 15 | 18.3 ± 4.2 | 14.4 ± 8.3 | 17.2 ± 10.9 | 5.1 ± 4.3 | 3.9 ± 2.3 |
| II | 66 | 17.9 ± 3.6 | 15.2 ± 9.7 | 16.5 ± 12.2 | 5.7 ± 3.6 | 4.2 ± 2.9 |
| III | 53 | 16.3 ± 4.0 | 15.9 ± 13.4 | 14.9 ± 13.3 | 7.2 ± 5.2 | 4.5 ± 3.4 |
| IV | 18 | 13.5 ± 5.3a | 13.1 ± 9.2 | 13.4 ± 9.4a | 9.3 ± 3.2a | 4.2 ± 2.7 |
| Serum (mmol/L) | ||||||
| I | 25 | 5.9 ± 0.8 | 1.5 ± 0.2 | 2.8 ± 1.1 | 1.5 ± 0.4 | 3.5 ± 1.3 |
| II | 113 | 4.8 ± 0.9 | 1.4 ± 0.3 | 1.9 ± 0.7 | 1.4 ± 0.3 | 3.1 ± 0.9 |
| III | 91 | 4.1 ± 1.0 | 1.4 ± 0.4 | 1.5 ± 0.9 | 1.4 ± 0.3 | 3.0 ± 0.9 |
| IV | 31 | 3.9 ± 0.9d | 1.3 ± 0.4 | 1.3 ± 0.5d | 1.1 ± 0.6 | 3.0 ± 0.8 |
a
P < 0.05 vs the levels of total cholesterol (TCH) and high density lipoprotein-cholesterol (HDL-C) in cancerous tissues with tumor node metastasis (TNM) stages;
d
P < 0.01 vs the levels of TCH and triglyceride (TG) in serum with TNM stages. LDL-C: Low density lipoprotein-cholesterol.